Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Annovis Bio Inc (NY: ANVS )

5.670 -0.060 (-1.05%)
Streaming Delayed Price Updated: 1:37 PM EST, Dec 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Annovis Bio Inc

< Previous 1 2 3 4 5 Next >
ANVS Stock Earnings: Annovis Bio Beats EPS for Q2 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Peering Into Annovis Bio's Recent Short Interest
Via Benzinga
Why Did Annovis Bio (ANVS) Stock Close Up 80% Today?
ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson's drug, buntanetap. 
Via InvestorPlace
Peering Into Annovis Bio's Recent Short Interest
Via Benzinga
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family 
Via Benzinga
What's Going On With Annovis Shares Today?
Annovis Bio shares rise in premarket trading on positive Phase III Parkinson's study results for buntanetap, showing cognitive improvements and stability compared to placebo. 
Via Benzinga
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory. 
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going With Annovis Bio Shares Tuesday?
Annovis announced new data from its Phase III Parkinson's study. The study showed improvements on the Unified Parkinson's Disease Rating Scale following treatment with Buntanetap. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Alzheimer's-Focused Annovis Bio Stock Nosediving On Monday?
Annovis Bio faces setbacks in Phase 2/3 Alzheimer's study, revealing minimal change in patients' conditions. Despite slight improvements in mild cases, results show no significant difference in... 
Via Benzinga
Stocks Quietly Climb Ahead Of Central Bank Storm
The Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 Index are all sporting comfortable leads this afternoon. 
Via Talk Markets
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023
ANVS stock results show that Annovis Bio missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Sell Signal: 3 Stocks to Unload Before the Bubble Bursts
It's time to offload stocks in the automotive, aerospace, and biotech sectors due to emerging financial and operational risks. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
3 Growth Stocks to Sell in February Before They Bottom
Discover why these growth stocks to sell are facing adversities in automotive retail, aerospace, defense and biotechnology. 
Via InvestorPlace
Dow Edges Lower; US Composite PMI Rises In January
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Rises Over 1%; DuPont Shares Plunge
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,040.66 while the NASDAQ rose 0.97% to 15,574.97. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.